The Aducanumab Aftermath: The Doctor

A costly, controversial new Alzheimer’s drug is sending shockwaves through the U.S. health care system. How are doctors grappling with questions about its safety and efficacy? This is the first episode in a special conversation series featuring different people reckoning with the potentially sweeping consequences this drug could have on millions of patients’ lives and billions of dollars in health care spending.

Guest: Winston Chiong, MD, PhD, Associate Professor of Neurology, University of California, San Francisco

Explore the full series and additional resources:

Read a transcript of this episode:

Sign up for our weekly newsletter to see what research health policy experts are reading right now, plus recommendations from our staff:

Support this type of journalism today, with a gift:

Follow us on Twitter:

See for privacy and opt-out information.